During the past decade, Rheumazentrum Prof. Dr. med Gunther Neeck conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rheumazentrum Prof. Dr. med Gunther Neeck" #1 sponsor was "Pfizer" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Galapagos NV" with 1 trials sponsored and "IBSA Institut Biochimique SA" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rheumazentrum Prof. Dr. med Gunther Neeck" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Rheumazentrum Prof. Dr. med Gunther Neeck" are "Rheumatoid Arthritis" (3 trials), "Arthritis, Rheumatoid" (2 trials), "Axial Spondyloarthritis" (1 trials), "Knee Osteoarthritis" (1 trials) and "Osteoarthritis" (1 trials). Many other conditions were trialed in "Rheumazentrum Prof. Dr. med Gunther Neeck" in a lesser frequency.

Most popular intervention types in "Rheumazentrum Prof. Dr. med Gunther Neeck" are "Drug" (8 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BI 695501" (2 trials), "Baricitinib" (1 trials), "Filgotinib" (1 trials) and "GP2013 - A Proposed biosimilar rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rheumazentrum Prof. Dr. med Gunther Neeck" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Rheumazentrum Prof. Dr. med Gunther Neeck". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Rheumazentrum Prof. Dr. med Gunther Neeck, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rheumazentrum Prof. Dr. med Gunther Neeck, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".